• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Sequent Scientific Ltd.
    04 Sep 2025
    182.51
    -0.55%
    Sequent and Viyash Life merger plan gets shareholder approval
    Sequent and Viyash Life merger plan gets shareholder approval
    Economic Times
    The proposed merger of Sequent Scientific and Viyash Life Sciences, backed by Carlyle, has received overwhelming shareholder support. This 8,000-crore merger aims to create a global entity, combining Sequent's animal health focus with Viyash's human health expertise. Hari Babu Bodepudi, the proposed group CEO, highlights opportunities in animal health generics and leveraging synergies between the companies' manufacturing capabilities.
    Copy LinkShare onShare on Share on Share on
    Sequent Scientific Ltd. has gained 33.98% in the last 6 Months
    logo
    Pfizer Ltd.
    03 Sep 2025
    5227.00
    1.15%
    Pfizer Defends Covid Shot, Says Trump Deserves Nobel Prize
    Pfizer Defends Covid Shot, Says Trump Deserves Nobel Prize
    NDTV Profit
    Vaccines have become a political flashpoint in recent years, with pundits questioning widely accepted evidence about their safety and efficacy.
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. is trading above its 200 day SMA of 4898.8
    logo
    Lupin Ltd.
    03 Sep 2025
    2043.40
    2.79%
    Lupin Gets USFDA Nod For Generic Risperidone Extended-Release Injectable Suspension
    Lupin Gets USFDA Nod For Generic Risperidone Extended-Release Injectable Suspension
    NDTV Profit
    The medicine had estimated annual sales of $190 million in the US, Lupin said, citing IQVIA moving annual toal July 2025 data.
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd.'s price crossed above 200Day SMA today
    Lupin gets USFDA nod for generic risperidone extended-release injectable suspension
    Business Line | 03 Sep 2025 1 more
    Lupin share price rises 3% as USFDA okays schizophrenia drug; details
    Business Standard | 03 Sep 2025
    logo
    Caplin Point Laboratories Ltd.
    03 Sep 2025
    2245.60
    0.36%
    Caplin Point's unit gets USFDA nod for generic milrinone lactate injection
    Business Standard
    Pharma firm Caplin Point Laboratories Ltd on Wednesday said its arm Caplin Steriles Ltd has received final approval from the US health regulator for its generic milrinone lactate in 5 per cent dextrose injection indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. The approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) milrinone lactate in 5 per cent Dextrose Injection of strengths 20 mg/100 mL and 40 mg/200 mL in single-dose infusion bags, Caplin Point Laboratories said in a regulatory filing. The approved injection is a generic therapeutic equivalent version of the reference listed drug PRIMACOR in dextrose 5 per cent, by Sanofi Aventis US LLC, it added. Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure, the company said. Citing IQVIA (IMS Health) data, the company said milrinone lactate in 5 per cent...
    Copy LinkShare onShare on Share on Share on
    Caplin Point Laboratories Ltd. is trading above all available SMAs
    logo
    Anlon Healthcare Ltd.
    03 Sep 2025
    10-year high
    109.43
    0.61%
    Anlon Healthcare makes flat D-street debut, lists at 92 on NSE SME
    Business Standard
    Post-listing, the Anlon Healthcare stock was trading at 91.5, up 0.55 per cent from the listing price on the BSE
    Copy LinkShare onShare on Share on Share on
    Hem Securities released a IPO Subscribe report for Anlon Healthcare Ltd. on 26 Aug, 2025.
    logo
    AstraZeneca Pharma India Ltd.
    02 Sep 2025
    Show Cause Notice
    9003.50
    -0.75%
    AstraZeneca surrenders its manufacturing licence in India
    Business Line
    The company is looking at importing its products from the 20-odd facilities it has across the world as part of a global review, said a source
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd. is trading above all available SMAs
    logo
    Concord Biotech Ltd.
    02 Sep 2025
    1639.00
    0.01%
    12 Dividend Stocks: Patanjali Foods, Concord Biotech, Prestige, Asahi Last Day To Buy Shares To Qualify
    12 Dividend Stocks: Patanjali Foods, Concord Biotech, Prestige, Asahi Last Day To Buy Shares To Qualify
    NDTV Profit
    VST Tillers Tractors has announced a final dividend of Rs 20, followed by Concord Biotech with a final dividend of Rs 10.70.
    Copy LinkShare onShare on Share on Share on
    Concord Biotech Ltd. has lost -22.31% in the last 3 Months
    logo
    Pfizer Ltd.
    01 Sep 2025
    5227.00
    1.15%
    'Want The Answer Now': Trump Wants Pfizer, Other Drugmakers To Justify Covid Vaccine Success
    'Want The Answer Now': Trump Wants Pfizer, Other Drugmakers To Justify Covid Vaccine Success
    NDTV Profit
    Trump claimed that companies like Pfizer had shown him "extraordinary" results but were not sharing them with the public.
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. has gained 28.57% in the last 6 Months
    logo
    Supriya Lifescience Ltd.
    01 Sep 2025
    647.60
    -0.90%
    Supriya Lifescience Eyes 33-35% Ebitda Margins In FY26 Led By New Products, US Expansion
    Supriya Lifescience Eyes 33-35% Ebitda Margins In FY26 Led By New Products, US Expansion
    NDTV Profit
    The company has already launched a new anaesthetic product in the first quarter of FY26, targeting a $300 million market.
    Copy LinkShare onShare on Share on Share on
    Supriya Lifescience .. has an average target of 800.00 from 1 broker.
    logo
    Anlon Healthcare Ltd.
    28 Aug 2025
    10-year high
    109.43
    0.61%
    Dr Agarwal's Eye Hospitals to merge with parent Dr Agarwal's Health Care
    Business Line
    As per the scheme, AHCL will issue and allot 23 new equity shares of face value of 1 each, for every two equity shares of face value of 10 held by eligible shareholders in AEH
    Copy LinkShare onShare on Share on Share on
    Hem Securities released a IPO Subscribe report for Anlon Healthcare Ltd. on 26 Aug, 2025.
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd